AIP-related indices

AIP-related indices has been studied in 1 paper since 2026: 1 observational study in people; 1 in the past year. The newest paper, Jun 14, 2026: “Associations of the atherogenic index of plasma and its modified indices with the incidence and progression of cardiometabolic multimorbidity in individuals with cardiovascular-kidney-metabolic syndrome stages 0-3: a prospective cohort study”.

Exposure

1 paper studies it3 findingsUpdated

See all 1 papers on AIP-related indices

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“All eight AIP-related indices were positively associated with incident CMM, with hazard ratios per 1-SD increment ranging from 1.12 to 1.37 (all P < 0.001).”
Associations of the atherogenic index of plasma and its modified indices with the incidence and progression of cardiometabolic multimorbidity in individuals with cardiovascular-kidney-metabolic syndrome stages 0-3: a prospective cohort studyCardiovascular diabetology2026doi:10.1186/s12933-026-03255-4

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • Funders: National Natural Science Foundation of China and 1 more
  • Humans1

What is AIP-related indices linked with?

3

Studies link AIP-related indices with 3 measures: transition from single cardiometabolic disease to multimorbidity involving coronary heart disease, transition from baseline to type 2 diabetes and incident cardiometabolic multimorbidity.

Transition from single cardiometabolic disease to multimorbidity involving coronary heart disease

upin humans1

1 study
  1. AIP-related indices are associated with transition from single cardiometabolic disease to multimorbidity involving coronary heart disease in humans (multistate model, stage-specific associations).

    “with stronger associations observed for the transition from baseline to T2DM and from single CMD to CMM involving CHD”

    Humansmultistate model, stage-specific associations

    Associations of the atherogenic index of plasma and its modified indices with the incidence and progression of cardiometabolic multimorbidity in individuals with cardiovascular-kidney-metabolic syndrome stages 0-3: a prospective cohort study

    Cardiovascular diabetology

More on Transition from single cardiometabolic disease to multimorbidity involving coronary heart disease

Transition from baseline to type 2 diabetes

upin humans1

1 study
  1. AIP-related indices are associated with transition from baseline to type 2 diabetes in humans (multistate model, stage-specific associations).

    “with stronger associations observed for the transition from baseline to T2DM and from single CMD to CMM involving CHD”

    Humansmultistate model, stage-specific associations

    Associations of the atherogenic index of plasma and its modified indices with the incidence and progression of cardiometabolic multimorbidity in individuals with cardiovascular-kidney-metabolic syndrome stages 0-3: a prospective cohort study

    Cardiovascular diabetology

More on Transition from baseline to type 2 diabetes

Incident cardiometabolic multimorbidity

upin humans1HR 1.12–1.37

1 study
  1. AIP-related indices are associated with incident cardiometabolic multimorbidity in humans (eight AIP-related indices, per 1-SD increment) (HR 1.12 to 1.37 per 1-SD increment).

    “All eight AIP-related indices were positively associated with incident CMM, with hazard ratios per 1-SD increment ranging from 1.12 to 1.37 (all P < 0.001).”

    Humanseight AIP-related indices, per 1-SD incrementmedian follow-up 15.9 yearsn = 346,868

    Associations of the atherogenic index of plasma and its modified indices with the incidence and progression of cardiometabolic multimorbidity in individuals with cardiovascular-kidney-metabolic syndrome stages 0-3: a prospective cohort study

    Cardiovascular diabetology

More on Incident cardiometabolic multimorbidity

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 1Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months